Breaking News


Cerus to Present at the Cowen and Company 34th Annual Health Care Conference, on March 4, 2014

  Cerus to Present at the Cowen and Company34th AnnualHealth Care   Conference, on March 4, 2014  Cowen and Company 34th Annual Healthcare Conference  Business Wire  CONCORD, Calif. -- February 27, 2014  Cerus Corporation (NASDAQ:CERS) announced today that William “Obi” Greenman, president and chief executive officer, is scheduled to present a corporate update at the Cowen and Company34^th AnnualHealth Care Conference at 11:20 AM ET on Tuesday, March 4, 2014.  A live webcast of the presentation will be available from the Investor Relations page of the Cerus web site at A replay will be available for approximately two weeks following the completion of the event.  ABOUT CERUS  Cerus Corporation is a biomedical products company focused in the field of blood safety. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. In the United States, Cerus is seeking regulatory approval of the INTERCEPT Blood System for plasma and platelets. The INTERCEPT red blood cell system is in clinical development. See for more information.  INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.  Contact:  Cerus Corporation Lainie Corten, 925-288-6319 Senior Director, Global Marketing & Investor Relations  
Press spacebar to pause and continue. Press esc to stop.